Digital Therapeutic (DTx) Market Market Size by Top Leading Key Players, Growth Opportunities, Incremental Revenue, Trends, Outlook and Forecasts to 2025

ReportsnReports provides in depth study of "Digital Therapeutic (DTx) Market" using SWOT analysis i.e. Strength, Weakness, Opportunities and Threat to the organisation. The Digital Therapeutic (DTx) Market report also provides an in-depth survey of key players in the market which is based on the various objectives of an organisation such as profiling, the product outline, the quantity of production, required raw material, and the financial health of the organisation.

The global Digital Therapeutic (DTx) Market is expected to witness a promising growth in the next few years. The rising level of competition among the leading players and the rising focus on the development of new products are likely to offer promising growth opportunities throughout the forecast period. The research study on the global Digital Therapeutic (DTx) Market offers a detailed overview, highlighting the key aspects that are expected to enhance the growth of the market in the near future. The key segmentation and the competitive landscape of the market have also been mentioned at length in the research study.

Get Free Sample Copy with Graphs, Figure and Toc's: https://www.reportsnreports.com/contacts/requestsample.aspx?name=610187

"Growing incidence of preventable chronic diseases and the need to control healthcare costs are the key factors driving the growth of the digital therapeutics market."

The global digital therapeutics market is projected to reach USD 6.9 billion by 2025 from USD 2.1 billion in 2020, at a CAGR of 26.7% during the forecast period. Growth in this market is mainly driven by the growing incidence of preventable chronic diseases, the need to control healthcare costs, and rising investments in digital therapeutics. On the other hand, a lack of awareness and access to digital therapeutics programs in developing countries, resistance from traditional healthcare providers, and unstable payment models are challenging the growth of this market.

Treatment/care-related applications segment accounted for the largest share of the digital therapeutics market in 2019

Based on application, the digital therapeutics market is segmented into preventive and treatment/care-related applications.Rising healthcare costs, the growing prevalence of chronic diseases, and the ability of digital therapeutics to provide cost-effective solutions are some factors responsible for driving the market for treatment/care-related digital therapeutics applications.

Get More Information About This Report: https://www.reportsnreports.com/contacts/discount.aspx?name=610187

Diabetes segment is expected to dominate the market

Based on the type of treatment/care-related application, the digital therapeutics market is further segmented into diabetes, CNS disorders, chronic respiratory diseases, musculoskeletal disorders, cardiovascular diseases, smoking cessation, medication adherence, gastrointestinal disorders, substance use disorders & addiction management, rehabilitation & patient care, and other treatment/care-related applications. The diabetes segment accounted for the largest share of the digital therapeutics market. The large share of this segment is attributed to the growing prevalence of diabetes across the globe. In addition, government initiatives to reduce the burden of diabetes using digital health are responsible for the large share of this segment.

B2B segment is expected to grow at the highest CAGR during the forecast period.

Based on the sales channel, the digital therapeutics market is segmented into business-to-customer (B2C) and business-to-business (B2B). The B2B segment is the largest and fastest-growing segment of the digital therapeutics market. The high preference of pharmaceutical companies to integrate digital therapeutics with their drug products to offer adherence services is a key factor driving the growth of this segment. Furthermore, rising awareness among payers, employers, and providers about the benefits of digital therapeutics has also supported the market growth.

Full Report Available with 20% Offers Apply the Coupon Code from the below Link: https://www.reportsnreports.com/purchase.aspx?name=610187

The primary interviews conducted for this report can be categorized as follows:

By Company Type: Tier 1 (32%), Tier 2 (44%), and Tier 3(24%)
By Designation: C-level (30%), D-level (34%), and Others(36%)
By Region: North America (40%), Europe (28%), Asia (20%), and the RoW (12%)

List of Companies Profiled in the Report

IBM Corporation (US)
SAS Institute, Inc. (US)
Oracle Corporation (US)
Quintiles, Inc. (US)
Accenture (Ireland)
Cognizant (US)
Wipro Limited (India)
MaxisIT Inc. (US)
TAKE Solutions (India)
SCIO Health Analytics (US)  

About Us:

ReportsnReports.com is your single source for all market research needs. Our database includes 500,000+ market research reports from over 95 leading global publishers & in-depth market research studies of over 5000 micro markets.

We provide 24/7 online and offline support to our customers.

E-mail: sales@reportsandreports.com

Phone: +1 888 391 5441

This release was published on openPR.